From a pharmaceutical strategy perspective, the findings elevate miR‑155 as a tissue‑level biomarker and potential target for ...

Aspira Women’s Health ( ($AWHL) ) has shared an update. On September 16, 2025, Aspira Women’s Health Inc. entered into securities purchase ...

Scientists at Wrocław Medical University in southwestern Poland report evidence that the mix of bacteria living in the human ...

Researchers identified microRNA-93 as a genetic driver of fatty liver disease and showed that vitamin B3 can effectively suppress it. This breakthrough suggests niacin could be repurposed as a ...

Highlights Independent institutional experience shows archival cytology slides enabled successful molecular results in cases previously ...

Million PIPE$112 thousand warrant exercise AUSTIN, TX / ACCESS Newswire / September 18, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's health ...

Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on surgery, chemotherapy, or radiotherapy.

What causes poor outcomes in patients with advanced peripheral artery disease who develop a complication called chronic ...

With limited treatment options for stroke patients available, two UConn researchers are developing an experimental drug that ...

The less time a tick has to feed, the less saliva it can pump in, and the fewer tricks it can use to tilt the odds. For ...

Mark W. Feinberg, MD, cardiologist with the Mass General Brigham Heart and Vascular Institute and professor of medicine at ...

Fatty liver disease, a growing global health concern, may have a new, inexpensive treatment option. A recent study identified ...